PD-L1 expression with immune-infiltrate evaluation and outcome prediction in melanoma patients treated with ipilimumab

Background: Tumor microenvironment may have a key role in providing immunological markers that can help predict clinical response to treatment with checkpoint inhibitors. We investigated whether the baseline expression of PD-L1 in advanced melanoma patients treated with ipilimumab may correlate with...

Descrición completa

Detalles Bibliográficos

Principais autores:	Gabriele Madonna, Carmen Ballesteros-Merino, Zipei Feng, Carlo Bifulco, Mariaelena Capone, Diana Giannarelli, Domenico Mallardo, Ester Simeone, Antonio M. Grimaldi, Corrado Caracò, Gerardo Botti, Bernard A. Fox, Paolo A. Ascierto
Formato:	Artigo
Idioma:	Inglês
Publicado:	Taylor & Francis Group 2018-12-01
Series:	OncoImmunology
Assuntos:	immunotherapy ipilimumab melanoma pd-l1 tumor microenvironment
Acceso en liña:	http://dx.doi.org/10.1080/2162402X.2017.1405206
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!